Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2008
12/04/2008US20080300239 Quinoline derivatives as pi3 kinase inhibitors
12/04/2008US20080300237 Pharmaceutically Active Diazepanes
12/04/2008US20080300236 Quinoline-derived amide modulators of vanilloid vr1 receptor
12/04/2008US20080300234 N-(1-Methyl-1-phenyl-ethyl)-3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-benzenesulfonamide, useful in the treatment of breast cancer
12/04/2008US20080300232 N-Piperidine Derivatives as Ccr3 Modulators
12/04/2008US20080299639 adduct comprising a molecule binding with a kinase; antiinflammatory agents; modulating activation state of p38 kinase protein; switch control ligands to induce or restrict conformation
12/04/2008DE102007025718A1 Pyridazinonderivate Pyridazinone derivatives
12/04/2008CA2688599A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/04/2008CA2688518A1 Pyridazinone derivatives for use in the treatment of a disease which is influenced by inhibiton of met kinase
12/04/2008CA2688517A1 Aryl ether pyridazinone derivatives for use in the treatment of tumours
12/04/2008CA2688375A1 Spirocyclopropyl piperidine derivatives
12/04/2008CA2688326A1 Tetrahydroisoquinolin-1-one derivative or salt thereof
12/04/2008CA2688110A1 Azacyclylbenzamide derivatives as histamine-3 antagonists
12/04/2008CA2687976A1 Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds
12/04/2008CA2687973A1 ((bicylicheteroaryl) imidazolyl)methylheteroaryl compounds as adrenergic receptor agonists
12/04/2008CA2687966A1 Thiazoles and pyrazoles useful as kinase inhibitors
12/04/2008CA2687942A1 Therapeutic agent for cerebral infarction
12/04/2008CA2687931A1 Ccr2 receptor antagonists and uses thereof
12/04/2008CA2687821A1 Benzimidazolone chymase inhibitors
12/04/2008CA2687625A1 3-(imidazolyl)-pyrazolo[3,4-b]pyridines
12/04/2008CA2687365A1 4,4-disubstituted piperidine derivatives
12/04/2008CA2687321A1 Pyridyl piperidine orexin receptor antagonists
12/04/2008CA2687132A1 4' substituted compounds having 5-ht6 receptor affinity
12/03/2008EP1997856A1 Optical recording medium and azo metal chelate compound
12/03/2008EP1997823A1 Boronic ester and acid compounds, synthesis and uses
12/03/2008EP1997818A2 Quinolinone derivatives and their use to treat pain
12/03/2008EP1997811A2 Indazole, benzoxazole and pyrazolopyridine derivatives as P38 kinase inhibitors
12/03/2008EP1997810A2 Indazole, benzoxazole and pyrazolopyridine derivatives for medical use
12/03/2008EP1997809A2 Indazole, benzoxazole and pyrazolopyridine derivatives for medical use
12/03/2008EP1997805A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/03/2008EP1997495A1 2-phenoxy- and 2-phenylsulfanyl-benzenesulfonamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
12/03/2008EP1996585A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/03/2008EP1996577A1 Heterocyclic substituted pyridine compounds with cxcr3 antagonist activity
12/03/2008EP1996576A1 Ccr5 antagonists useful for treating hiv
12/03/2008EP1996575A2 Crystal form of besipirdine chlorhydrate, process preparation and use thereof
12/03/2008EP1996574A1 Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
12/03/2008EP1996562A1 Substituted 4-amino-quinazoline derivatives as regulators of metabotropic glutamate receptors and their use for producing drugs
12/03/2008EP1996558A1 Heterobicyclic carboxamides as inhibitors for kinases
12/03/2008EP1996555A1 Compounds which potentiate ampa receptor and uses thereof in medicine
12/03/2008EP1996553A2 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
12/03/2008EP1996550A2 Carboxyamine compounds and their use in the treatment of hdac dependent diseases
12/03/2008EP1996548A1 Sigma receptor compounds
12/03/2008EP1996546A2 Substituted gamma lactams as prostaglandin ep2 agonists
12/03/2008EP1996545A1 Soluble epoxide hydrolase inhibitors and methods of using same
12/03/2008EP1778633B1 Indoles useful in the treatment of inflammation
12/03/2008EP1737463B1 Pyrimidines with tie2 (tek) activity
12/03/2008EP1492785B1 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
12/03/2008EP1480954B1 Vanilloid receptor modulators
12/03/2008EP1426371B1 Tetrazoyl oxime derivatives and agrochemicals containing the same as the active ingredient
12/03/2008EP1423388B1 2-arylamino-pyrimidines for the treatment of gsk3-related disorders
12/03/2008EP1377540B1 Inhibitors of integrin alpha-v-beta-6
12/03/2008EP1373218B9 Imidazolyl derivatives useful as histamine h3 receptor ligands
12/03/2008EP1068202B1 1-(3-heteroarylpropyl- or -prop-2-enyl)-4-benzylpiperidines used as nmda receptor antagonists
12/03/2008CN101316841A Arylmethylene urea derivative and use thereof
12/03/2008CN101316840A 1,5-substituted indol-2-yl amide derivatives
12/03/2008CN101316839A Acid addition salt of dihydropyridine derivative
12/03/2008CN101316838A 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators
12/03/2008CN101316837A Substituted pyrrolones as allosteric modulators of glucokinase
12/03/2008CN101316836A Substituted dihydroisoindolones as allosteric modulators of glucokinase
12/03/2008CN101316835A 5-substituted indole-2-carboxamide derivatives
12/03/2008CN101316834A 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent PARP inhibitors
12/03/2008CN101316823A 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and MDM2 proteins for use as anticancer agents
12/03/2008CN101316587A 取代的吡唑化合物 Substituted pyrazole compounds
12/03/2008CN101314595A Aromatic hydrocarbons connected multi-polyamine large-ring derivants, preparation method and medical use thereof
12/03/2008CN100439359C Indolylmaleimide derivatives
12/03/2008CN100439357C Benzo [b][1,4] dioxepine derivatives
12/03/2008CN100439344C 4-anilino quinazoline derivatives as antiproliferative agents
12/03/2008CN100439341C Indazole derivatives as CRF antagonists
12/03/2008CN100439340C 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
12/03/2008CN100439339C 2-pyridone derivatives as netrophil elastase inhibitors and their use.
12/03/2008CN100439337C Phenyl substituted piperidine compounds for use as PPAR activators
12/03/2008CN100438872C Method of stabilizing lipid-rich plaque and method of preventing rupture thereof
12/02/2008US7459580 Process for trans-4-amino-1-cyclohexanecarboxilic acid derivatives
12/02/2008US7459566 1,2,4-oxadiazol-5-one-4-(benzimidazolylmethylamino)benzamidine compounds
12/02/2008US7459562 Monocyclic heterocycles as kinase inhibitors
12/02/2008US7459561 Containing pyridine, phenyl, thiazole and triazole rings, e.g., 1-[[N-methyl-N-3-[(methylamino)acetoxymethyl]pyridin-2-yl]carbamoyloxy]ethyl-1-[(2R,3R)-2-(2,4-difluorophenyl)-2-hydroxy-3-[4-(4-cyanophenyl)thiazol-2-yl ]butyl]-1H-[1,2,4]triazol-4-ium chloride; parenteral treatment of fungal diseases
12/02/2008US7459556 Process for preparing substituted 8-azabicyclo[3.2.1]octan-3-ols
12/02/2008US7459552 Reacting N-[2,4-bis(methylthio)-6-methylpyridin-3-yl]-2-[4-(2-hydroxyethyl)piperazin-1-yl]acetamide with 5-benzyloxy-2-mercaptobenzimidazole in presence of triphenylphosphine and diethyl azodicarboxylate; acyl-coenzyme A cholesterol acyltransferase (ACAT) inhibitor
12/02/2008US7459480 Benzodioxepine derivatives
12/02/2008US7459473 1-(phenylmethyl)sulfonyl-2-hydroxymethyl pyrrolidine for example; use treating neurological disorders including physically damaged nerves and neurodegenerative diseases; treating alopecia and promoting hair growth
12/02/2008US7459470 For example, N-(Isoquinolin-3-yl)-2-(4-pyridylmethyl)aminobenzoic acid amide-N-oxide; use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, such as psoriasis, arthritis, hemangioma, angiofibroma, eye diseases, cirrhosis of the liver
12/02/2008US7459466 Antiinflammatory agents; autoimmune diseases; anticancer agents
12/02/2008US7459465 Isoquinoline compound and pharmaceutical use thereof
12/02/2008US7459462 Water soluble groups on ring A; antitumor antibiotics; 1-Desoxy-5-C-[(8R)-4',9,9'-trihydroxy-6'-methoxy-1,1',3',5',8'-pentaoxo-1,1',2,3',5',6,7,8'-octahydrospiro[cyclopenta[g]isoquinoline-8,2'-cyclopenta[b]-naphthalene]-3-yl]pentitol; topoisomerase inhibitors; cyclodextrin inclusions; stereoisomers
12/02/2008US7459460 Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators
12/02/2008US7459457 Polycyclic pyridines as potassium ion channel modulators
12/02/2008US7459456 e.g. 3-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-oxazolidin-2-one; serotonin receptor antagonist and inverse agonists, agonists or partial agonists, serotonin reuptake inhibitor; antidepressant, anxiolytic agent
12/02/2008US7459454 Aminopyrazine derivatives and compositions
12/02/2008US7459453 Pyridazin-3(2H)-one derivatives as PDE4 inhibitors
12/02/2008US7459452 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
12/02/2008CA2461622C Substituted benzimidazole compounds and their use for the treatment of cancer
12/02/2008CA2424600C Aliphatic nitrogenous five-membered ring compounds
12/02/2008CA2361841C Mevinolin derivatives
12/02/2008CA2344144C Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
12/02/2008CA2305548C Prostaglandin agonists and their use to treat bone disorders
12/02/2008CA2265672C Pyrazinones and triazinones and their derivatives thereof
12/02/2008CA2186380C Novel carbamates and ureas as modifiers of multi-drug resistance
11/2008
11/27/2008WO2008144305A1 Diaryl-substituted tetrahydroisoquinolines as histamine h3 receptor and serotonin transporter modulators
11/27/2008WO2008144299A1 5- (aminoazacyclyl) -3-sulfonyl-lh- indazoles as 5-hydroxytryptamine- 6 ligands for the treatment of cns disorders
11/27/2008WO2008144266A1 Spiroindalones